Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of high-purity rifapentine

A rifapentine, high-purity technology, applied in the field of medicine, can solve the problems of insufficient rifapentine purity and unsatisfactory use effect, and achieve the effects of improving stability, reducing production, and increasing speed

Inactive Publication Date: 2020-04-17
WUXI FORTUNE PHARMA
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The mechanism of action of rifapentine is the same as that of rifampicin. It binds firmly to the subunit of DNA-dependent RNA polymerase, inhibits the synthesis of bacterial RNA, prevents the enzyme from connecting with DNA, thereby blocking the RNA transcription process and making DNA and protein The synthesis is stopped, but in the prior art, the purity of rifapentine is not enough, and the use effect is not satisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of high-purity rifapentine
  • Preparation method of high-purity rifapentine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] The present invention will be described in detail below in conjunction with various embodiments, but it should be noted that these embodiments are not limitations of the present invention, and those of ordinary skill in the art can make functional, method, or structural equivalent transformations or replacements based on these embodiments. , all fall within the protection scope of the present invention.

[0025] This embodiment discloses a preparation method of high-purity rifapentine, comprising the following steps:

[0026] Step 1: cyclization reaction of rifamycin S acid, acid, and dimethylol terbumine in N,N-dimethylformamide solvent; the amount of acid in the cyclization reaction is the amount of rifamycin S acid 0.3 to 0.4 times (v / w), the pH value is under acidic conditions, and the ring-opening reaction is a two-way reaction, which is beneficial to the forward reaction in an acidic synthesis environment and is helpful to the improvement of purity.

[0027] Step...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation method of high-purity rifapentine, which is characterized by comprising the following steps: 1. carrying out a cyclization reaction on rifamycin S acid, acid and dimethyloltert-butylamine in an N, N-dimethylformamide solvent; 2, pouring the reaction solution into acid water, standing, and filtering to obtain a rifaxizine filter cake; 3, adding urea, n-butyl alcohol, Vc and sodium carbonate into the rifaxizine filter cake for a ring-opening reaction; 4, after the reaction is completed, increasing the purity to 1-amino-4-cyclopentylpiperazine for a condensation reaction until the reaction is completed so as to obtain a rifapentine reaction solution; and step 5, dropwise adding acid water into the rifapentine reaction solution, stirring, stopping heating after crystallization, lowering the rotating speed after turning red, cooling after dropwise adding is finished, filtering to obtain the filter cake, and carrying out secondary recrystallization on thefilter cake. According to the preparation method of the high-purity rifapentine, provided by the invention, the maximum single impurity of the rifapentine can be controlled within 0.1%, and the residual n-butyl alcohol and the residual ethanol can be controlled within 0.5%.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a preparation method of high-purity rifapentine. Background technique [0002] Rifapentine is an anti-tuberculosis drug produced through a synthetic reaction based on the raw material of rifamycin S acid, and its chemical structural formula is as follows: [0003] [0004] Rifapentine is a semi-synthetic broad-spectrum fungicide, which has strong antibacterial activity against Mycobacterium tuberculosis in vitro, with a minimum inhibitory concentration (MIC) of 0.12-0.25 mg / L, which is 2-10 times stronger than rifampicin; The anti-tuberculosis infection in mice is also better than rifampicin. Bacillus leprae and other mycobacteria such as Mycobacterium kansasii and Mycobacterium xenopus are also sensitive to this product, but Mycobacterium avium is resistant. In addition, this product has high antibacterial activity against most Gram-positive cocci, and its MIC<0.025mg / L...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D498/08
CPCC07D498/08
Inventor 顾玉峰王勇刘然严伟伟许康
Owner WUXI FORTUNE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products